Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy

Savès, Marianne; Raffi, François; Capeau, Jacqueline; Rozenbaum, Willy; Ragnaud, Jean‐Marie; Perronne, Christian; Basdevant, Arnaud; Leport, Catherine; Chêne, Geneviève; Antiproteases Cohorte (APROCO) Study Group, the

doi:10.1086/339866

Public

Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy

Published in Clinical Infectious Diseases • May 15, 2002

Authors:

Marianne Savès

François Raffi

Jacqueline Capeau

Abstract

Morphologic and metabolic changes associated with protease inhibitor (PI) therapy have been reported since the introduction of PIs for treatment of human immunodeficiency virus infection. These changes were measured 12-20 months after initiation of PI therapy in a cross-sectional study involving 614...

Subject

Lipodystrophy

Medicine

Stavudine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!